In the case of epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer (NSCLC), age-related factors might be less influential because the first-line treatment generally comprises a monotherapy with EGFR tyrosine kinase inhibitors (TKIs). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.